preclinical models
PDX-derived cells
PDX resources
patient-derived cancer Xenografts
advanced PDX
humanised models
PDX quality control
European Research Area
Joint Research Activities
Patient-derived tumour xenografts
preclinical tools
preclinical platforms
cutting-edge European infrastructure
NAs
global cooperation of research infrastructures
industrial cancer researchers
therapeutic mouse trials
EurOPDX Distributed Infrastructure
optimal therapeutic management of cancer patients
TA initiatives
development of exploratory
tumour fragments
Networking Activities
User outreach
oncology drug development
inter-laboratory procedures
wide dissemination of services
establishment of standard procedures
structured biobanking of user
overall goal of EDIReX
cross-validation mouse trial
high attrition rates
long-term storage
user-friendly query
animal experimentation
Trans-national Access
visualisation of clinical
parties
target
public Data Portal
project results
adoption of shared ethics parameters
implementation
complexity
orthotopic
PDXs
distribution of cryopreserved samples
pharmacological annotation
design of plans
scientific community
biomarker discovery
pronged approach
reliability of service provision
diversity of human tumours
immunodeficient mice
sustainability
interoperability
performance of efficacy studies
Capitalising
assets